Stockscreener 앱 받기
36.12
0.91%
-0.33
시간 외 거래:
41.15
5.03
+13.93%
전일 마감가:
$36.45
열려 있는:
$35.67
하루 거래량:
1.23M
Relative Volume:
1.22
시가총액:
$2.84B
수익:
$399.58M
순이익/손실:
$-54.04M
주가수익비율:
-48.16
EPS:
-0.75
순현금흐름:
$40.13M
1주 성능:
+1.46%
1개월 성능:
+0.33%
6개월 성능:
+19.01%
1년 성능:
+3.26%
1일 변동 폭
$35.26
$36.96
1주일 범위
$34.84
$36.96
52주 변동 폭
$22.61
$47.32
Veracyte Inc Stock (VCYT) Company Profile
명칭
Veracyte Inc
전화
(650) 243-6300
주소
6000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO, CA
VCYT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
VCYT
Veracyte Inc
|
36.12 | 2.87B | 399.58M | -54.04M | 40.13M | -0.75 |
|
TMO
Thermo Fisher Scientific Inc
|
565.24 | 212.23B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
213.83 | 151.20B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
722.12 | 57.84B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
146.08 | 41.02B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
210.96 | 36.42B | 15.90B | 1.28B | 2.21B | 7.2842 |
Veracyte Inc Stock (VCYT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-20 | 개시 | Canaccord Genuity | Hold |
| 2025-03-20 | 개시 | Craig Hallum | Buy |
| 2024-12-05 | 다운그레이드 | Goldman | Buy → Neutral |
| 2024-11-15 | 개시 | Wolfe Research | Outperform |
| 2024-10-16 | 개시 | UBS | Buy |
| 2024-10-10 | 개시 | Guggenheim | Buy |
| 2024-02-23 | 재확인 | Needham | Buy |
| 2023-01-18 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2023-01-05 | 개시 | Scotiabank | Sector Outperform |
| 2022-01-07 | 개시 | Stephens | Overweight |
| 2021-11-18 | 재개 | Goldman | Buy |
| 2021-06-15 | 개시 | Raymond James | Outperform |
| 2021-02-18 | 재개 | Needham | Buy |
| 2021-01-28 | 개시 | Truist | Buy |
| 2020-11-10 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2020-09-09 | 개시 | Morgan Stanley | Underweight |
| 2019-07-31 | 개시 | Lake Street | Buy |
| 2019-07-02 | 개시 | Needham | Buy |
| 2018-11-29 | 다운그레이드 | Janney | Buy → Neutral |
| 2018-10-31 | 업그레이드 | Janney | Neutral → Buy |
| 2017-11-07 | 다운그레이드 | Janney | Buy → Neutral |
| 2017-11-07 | 다운그레이드 | Piper Jaffray | Overweight → Neutral |
| 2017-08-31 | 재개 | BTIG Research | Buy |
| 2016-11-14 | 재개 | Leerink Partners | Outperform |
| 2015-12-18 | 개시 | Cantor Fitzgerald | Buy |
| 2015-06-11 | 재확인 | Leerink Partners | Outperform |
| 2013-11-26 | 개시 | William Blair | Outperform |
모두보기
Veracyte Inc 주식(VCYT)의 최신 뉴스
Veracyte Q3 2025 presentation slides: revenue up 14%, EBITDA margin hits 30% - Investing.com
Earnings call transcript: Veracyte Q3 2025 beats EPS expectations - Investing.com
Veracyte: Q3 Earnings Snapshot - News-Times
Veracyte shares soar as Q3 results beat estimates, guidance raised - Investing.com India
Earnings Flash (VCYT) Veracyte, Inc. Reports Q3 Revenue $131.9M, vs. FactSet Est of $125.0M - MarketScreener
Why Veracyte’s Stock is on the Move - TipRanks
Veracyte’s Revenue And Outlook Lift Expectations For 2025 - Finimize
Veracyte Inc earnings beat by $0.19, revenue topped estimates - Investing.com
Genomic diagnostics firm Veracyte Q3 revenue beats estimates on higher testings - MarketScreener
Veracyte Announces Third Quarter 2025 Financial Results - Business Wire
How Veracyte Inc. stock performs in interest rate cyclesJuly 2025 Recap & Expert Curated Trade Ideas - newser.com
Heatmap analysis for Veracyte Inc. and competitorsDividend Hike & Low Drawdown Trading Strategies - newser.com
Short interest data insights for Veracyte Inc.Earnings Risk Report & Verified Trade Idea Suggestions - newser.com
Is Veracyte Inc. a candidate for recovery playJuly 2025 Closing Moves & Low Risk Investment Opportunities - newser.com
Can Veracyte Inc. (12V) stock ride next bull market cycleWeekly Trade Summary & Stepwise Entry and Exit Trade Signals - newser.com
Chart based analysis of Veracyte Inc. trendsJuly 2025 Opening Moves & Safe Entry Zone Tips - newser.com
Technical analysis overview for Veracyte Inc. stockSell Signal & Free Safe Capital Growth Stock Tips - newser.com
Can Veracyte Inc. stock beat market expectations this quarterTrend Reversal & Safe Capital Allocation Plans - newser.com
How to read the order book for Veracyte Inc.July 2025 Momentum & Accurate Entry and Exit Point Alerts - newser.com
Will Veracyte Inc. stock remain a Wall Street favoriteJuly 2025 News Drivers & Reliable Volume Spike Alerts - newser.com
Veracyte (VCYT) Studies Highlight Afirma GRID's Role in Thyroid Cancer Research - GuruFocus
Veracyte Announces First Publications Using Afirma GRID Research Tool To Help Usher in Next Generation of Thyroid Nodule Testing - Business Wire
Wakefield Asset Management LLLP Buys New Holdings in Veracyte, Inc. $VCYT - MarketBeat
What To Expect From Veracyte Inc (VCYT) Q3 2025 Earnings - Yahoo Finance
Can swing trading help recover from Veracyte Inc. lossesJuly 2025 Setups & Weekly Breakout Stock Alerts - newser.com
What to do if you’re stuck in Veracyte Inc.2025 Top Decliners & Community Verified Trade Alerts - newser.com
Veracyte, Inc. $VCYT Shares Bought by AlphaQuest LLC - MarketBeat
Veracyte Inc Stock Analysis and ForecastEarnings Date Calendar & Build Winning Strategies With Zero Cost - earlytimes.in
Will Veracyte Inc. stock benefit from commodity pricesChart Signals & Risk Managed Investment Signals - newser.com
Automated trading signals detected on Veracyte Inc.Oil Prices & Fast Entry and Exit Trade Plans - newser.com
How Veracyte Inc. stock reacts to job market data2025 Geopolitical Influence & Verified Momentum Stock Alerts - newser.com
Tools to assess Veracyte Inc.’s risk profileWeekly Risk Report & Growth-Oriented Investment Plans - newser.com
Jennison Associates LLC Sells 734,486 Shares of Veracyte, Inc. $VCYT - MarketBeat
Using portfolio simulators with Veracyte Inc. includedPortfolio Update Report & Real-Time Chart Pattern Alerts - newser.com
What MACD trends signal for Veracyte Inc. (12V) stock2025 Earnings Impact & Risk Controlled Daily Trade Plans - newser.com
Q3 2025 Earnings Call - MarketScreener
Veracyte Inc (VCYT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.45%
6.29%
자본화:
|
볼륨(24시간):